GB2140008B - Niflumic acid morpholinoethyl ester diniflumate - Google Patents
Niflumic acid morpholinoethyl ester diniflumateInfo
- Publication number
- GB2140008B GB2140008B GB08409104A GB8409104A GB2140008B GB 2140008 B GB2140008 B GB 2140008B GB 08409104 A GB08409104 A GB 08409104A GB 8409104 A GB8409104 A GB 8409104A GB 2140008 B GB2140008 B GB 2140008B
- Authority
- GB
- United Kingdom
- Prior art keywords
- niflumic acid
- morpholinoethyl ester
- diniflumate
- acid morpholinoethyl
- ester diniflumate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 Niflumic acid morpholinoethyl ester Chemical class 0.000 title 1
- 229960000916 niflumic acid Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8306579A FR2544718B1 (fr) | 1983-04-21 | 1983-04-21 | Diniflumate d'ester morpholinoethylique d'acide niflumique, preparation, utilisation en therapeutique comme analgesique et anti-inflammatoire |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8409104D0 GB8409104D0 (en) | 1984-05-16 |
| GB2140008A GB2140008A (en) | 1984-11-21 |
| GB2140008B true GB2140008B (en) | 1986-11-12 |
Family
ID=9288097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08409104A Expired GB2140008B (en) | 1983-04-21 | 1984-04-09 | Niflumic acid morpholinoethyl ester diniflumate |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4595686A (enExample) |
| EP (1) | EP0129449B1 (enExample) |
| JP (1) | JPS59199676A (enExample) |
| KR (1) | KR880001477B1 (enExample) |
| AR (1) | AR240314A1 (enExample) |
| AT (1) | ATE33639T1 (enExample) |
| AU (1) | AU561210B2 (enExample) |
| CA (1) | CA1218064A (enExample) |
| DE (1) | DE3470534D1 (enExample) |
| DK (1) | DK157858C (enExample) |
| EG (1) | EG17886A (enExample) |
| ES (1) | ES8502111A1 (enExample) |
| FR (1) | FR2544718B1 (enExample) |
| GB (1) | GB2140008B (enExample) |
| GR (1) | GR81476B (enExample) |
| HU (1) | HU194877B (enExample) |
| IE (1) | IE57219B1 (enExample) |
| IL (1) | IL71525A (enExample) |
| MA (1) | MA20097A1 (enExample) |
| MY (1) | MY100483A (enExample) |
| NZ (1) | NZ207913A (enExample) |
| PH (1) | PH18986A (enExample) |
| PT (1) | PT78432B (enExample) |
| SG (1) | SG107587G (enExample) |
| YU (1) | YU65784A (enExample) |
| ZA (1) | ZA842672B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5192724A (en) * | 1992-03-17 | 1993-03-09 | Phillips Petroleum Company | Reactivation of spent cracking catalysts |
| GB0006897D0 (en) * | 2000-03-23 | 2000-05-10 | Smithkline Beecham Plc | Medicaments |
| CA2450073C (en) | 2001-07-25 | 2017-08-29 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| EP2671508B1 (en) | 2005-04-28 | 2020-09-16 | Proteus Digital Health, Inc. | Pharma-informatics system |
| JP2010503710A (ja) | 2006-09-18 | 2010-02-04 | ラプトール ファーマシューティカル インコーポレイテッド | 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置 |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| KR20180114970A (ko) | 2009-05-06 | 2018-10-19 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US27822A (en) * | 1860-04-10 | Isaac mott | ||
| GB1146459A (en) * | 1966-11-14 | 1969-03-26 | American Cyanamid Co | Nicotinic acid derivatives and method of preparing the same |
| GB1187259A (en) * | 1967-10-23 | 1970-04-08 | Hexachimie | New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture |
| USRE27822E (en) | 1971-07-06 | 1973-11-27 | Substituted phenoxy-z-hydroxy- j-isopropylamino-propanes | |
| DE2601548C2 (de) * | 1976-01-16 | 1984-01-26 | Hoechst Ag, 6230 Frankfurt | 2-[4-(2'-Chlor-4'-bromphenoxy)-phenoxy]-propionsäure und Derivate sowie diese enthaltende herbizide Mittel |
| AR208619A1 (es) * | 1976-09-02 | 1977-02-15 | Bago Sa Labor | Un procedimiento para la obtencion de 2(3'-trifluormetilanilino)nicotinato de 5-hidroxi-6-metil-3,4-piridina dimetano |
| US4386090A (en) * | 1980-12-22 | 1983-05-31 | Delalande S.A. | Nitrogen containing 2,3-dihydro naphthalenes, compositions and use |
| IT1150194B (it) * | 1982-02-23 | 1986-12-10 | Chiesi Farma Spa | Formulazioni farmaceutiche ad attivita'antiinfiammatoria, analgesica,antipiretica e gastroprotettiva |
-
1983
- 1983-04-21 FR FR8306579A patent/FR2544718B1/fr not_active Expired
-
1984
- 1984-04-05 IE IE843/84A patent/IE57219B1/xx unknown
- 1984-04-09 US US06/597,808 patent/US4595686A/en not_active Expired - Fee Related
- 1984-04-09 GB GB08409104A patent/GB2140008B/en not_active Expired
- 1984-04-10 YU YU00657/84A patent/YU65784A/xx unknown
- 1984-04-10 AR AR296242A patent/AR240314A1/es active
- 1984-04-11 AU AU26748/84A patent/AU561210B2/en not_active Ceased
- 1984-04-11 ZA ZA842672A patent/ZA842672B/xx unknown
- 1984-04-12 IL IL71525A patent/IL71525A/xx unknown
- 1984-04-17 PT PT78432A patent/PT78432B/pt not_active IP Right Cessation
- 1984-04-17 CA CA000452208A patent/CA1218064A/en not_active Expired
- 1984-04-17 ES ES531679A patent/ES8502111A1/es not_active Expired
- 1984-04-18 PH PH30587A patent/PH18986A/en unknown
- 1984-04-18 GR GR74463A patent/GR81476B/el unknown
- 1984-04-18 DK DK200884A patent/DK157858C/da not_active IP Right Cessation
- 1984-04-19 NZ NZ207913A patent/NZ207913A/en unknown
- 1984-04-19 KR KR1019840002063A patent/KR880001477B1/ko not_active Expired
- 1984-04-19 JP JP59077626A patent/JPS59199676A/ja active Pending
- 1984-04-20 DE DE8484400813T patent/DE3470534D1/de not_active Expired
- 1984-04-20 AT AT84400813T patent/ATE33639T1/de not_active IP Right Cessation
- 1984-04-20 EP EP84400813A patent/EP0129449B1/fr not_active Expired
- 1984-04-20 MA MA20318A patent/MA20097A1/fr unknown
- 1984-04-20 HU HU841552A patent/HU194877B/hu not_active IP Right Cessation
- 1984-04-21 EG EG252/84A patent/EG17886A/xx active
-
1987
- 1987-10-01 MY MYPI87002704A patent/MY100483A/en unknown
- 1987-12-08 SG SG1075/87A patent/SG107587G/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2154586B (en) | Phenoxyalkanoic acid esters | |
| DE3477669D1 (en) | Dihydropyridine-5-phosphonic acid cyclic ester | |
| EG18042A (en) | Novel androstane-17beta-carboxylic acid esters | |
| GB8409104D0 (en) | Niflumic acid morpholinoethyl ester | |
| GB2145411B (en) | Gametocidal pyridazinylcarboxylic acid derivatives | |
| ZW6786A1 (en) | Vinylcyclopropanecarboxylic acid esters | |
| GB8419279D0 (en) | Octahydroindolizine-propanoic acid derivatives | |
| GB2162514B (en) | Thiazolylpropenedicarboxylic acid half esters | |
| GB2137193B (en) | Chlorosulphonic acid esters | |
| GB8507908D0 (en) | Acid derivatives | |
| GB2137985B (en) | Phenylacetic acid esters | |
| ZA859601B (en) | Pyridyl-thionophosphoric acid esters | |
| ZA859517B (en) | Pyrimidinyl-thionophosphoric acid esters | |
| GB2134111B (en) | Pyrrole-2-acetylamino acid derivatives | |
| SG34387G (en) | Esters of 2-carbamoyloxymethyl-6-hydroxyethyl-2-penem-3-carboxylic acid | |
| ZA842131B (en) | Substituted phenoxypropionic acid esters | |
| IL79464A0 (en) | Naphthyridine-carboxylic acid esters | |
| ZA855262B (en) | Pyrimidinyl-thionophosphoric acid esters | |
| DE3366930D1 (en) | New phenylthionophosphonic acid esters | |
| ZA863307B (en) | Permethric acid triazolyl-alkyl esters | |
| GB2151615B (en) | Malonyl-oxacephemcarboxylic acid derivatives | |
| GB2139226B (en) | Naphthyloxyalkylcarboxylic acid derivatives | |
| IE831236L (en) | Dihydrolysergic acid esters | |
| LTIP960A (en) | Acrylic acid derivatives | |
| NZ225134A (en) | Thiomeandelic acid esters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |